Recent preclinical studies have revealed that the response to DNA damages (e.g. DNA double-strand breaks, DNA single-strand breaks and base damage) upregulates PD-L1 expression in cancer cells via ATM/ATR/Chk1 kinase activation [47–49]. Here, CD274 is linked to cancer.